BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15470446)

  • 1. Biotech patenting matures.
    Lawrence S
    Nat Biotechnol; 2004 Oct; 22(10):1202. PubMed ID: 15470446
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights into US public biotech sector using patenting trends.
    Aggarwal S; Gupta V; Bagchi-Sen S
    Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech patents still strong.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1341. PubMed ID: 18066014
    [No Abstract]   [Full Text] [Related]  

  • 5. Enthusiasm cools in Q2.
    Lawrence S
    Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech patenting upturn.
    Lawrence S
    Nat Biotechnol; 2006 Oct; 24(10):1190. PubMed ID: 17033646
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent drop reveals pressures on industry.
    Lawrence S
    Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
    [No Abstract]   [Full Text] [Related]  

  • 8. Shares in the human genome--the future of patenting DNA.
    Thomas SM; Hopkins MM; Brady M
    Nat Biotechnol; 2002 Dec; 20(12):1185-8. PubMed ID: 12454661
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotech financing retrenches in Q2.
    Lawrence S
    Nat Biotechnol; 2006 Aug; 24(8):883. PubMed ID: 16900116
    [No Abstract]   [Full Text] [Related]  

  • 10. 2007--a banner year for biotech.
    Lawrence S
    Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
    [No Abstract]   [Full Text] [Related]  

  • 11. State of biotech sector--2005.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in nanotechnology patents.
    Chen H; Roco MC; Li X; Lin Y
    Nat Nanotechnol; 2008 Mar; 3(3):123-5. PubMed ID: 18654475
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of gene patenting on R&D and commerce.
    Stott M; Valentine J
    Nat Biotechnol; 2003 Jul; 21(7):729-31; author reply 731. PubMed ID: 12833081
    [No Abstract]   [Full Text] [Related]  

  • 14. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. University biotech patenting 2013.
    Huggett B; Paisner K
    Nat Biotechnol; 2014 Jun; 32(6):512. PubMed ID: 24911487
    [No Abstract]   [Full Text] [Related]  

  • 16. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA patenting: the end of an era?
    Hopkins MM; Mahdi S; Patel P; Thomas SM
    Nat Biotechnol; 2007 Feb; 25(2):185-7. PubMed ID: 17287750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 19. Research biotech patenting 2014.
    Huggett B; Paisner K
    Nat Biotechnol; 2015 Jul; 33(7):684. PubMed ID: 26154000
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent holdings of US biotherapeutic companies in major markets.
    Sebastian TE; Yerram CB; Saberwal G
    Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.